Abstract
Ron, the receptor tyrosine kinase (RTK) for the macrophage stimulating protein (MSP), activates multiple signaling pathways by recruiting several positive regulators to a multifunctional docking site. Here we show that stimulation by MSP also recruits a negative regulator, the c-Cbl ubiquitin ligase, to the multifunctional docking site as well as to a juxtamembrane tyrosine autophosphorylation site. c-Cbl recruitment to these two sites results in polyubiquitylation of Ron molecules, which are subsequently sorted for endocytosis and degradation. Both the phosphotyrosine binding domain of c-Cbl and its RING domain are essential for downregulation of Ron. Although Ron and c-Cbl are found also in physical complexes that include Grb2, these associations are insufficient for productive ubiquitylation of Ron. Our results shed light on the mechanism of receptor desensitization mediated by c-Cbl and its binding partner Grb2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen YQ, Fisher JH and Wang MH . (1998). J. Immunol., 161, 4950–4959.
Chen YQ, Zhou YQ, Angeloni D, Kurtz AL, Qiang XZ and Wang MH . (2000). Exp. Cell Res., 261, 229–238.
Comoglio PM and Trusolino L . (2002). J. Clin. Invest., 109, 857–862.
Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T and Bernstein A . (1997). Genes Funct., 1, 69–83.
Danilkovitch A, Skeel A and Leonard EJ . (1999). Exp. Cell Res., 2, 575–582.
Danilkovitch-Miagkova A and Leonard EJ . (2001). Apoptosis, 6, 183–190.
Feshchenko EA, Langdon WY and Tsygankov AY . (1998). J. Biol. Chem., 273, 8323–8331.
Feshchenko EA, Shore SK and Tsygankov AY . (1999). Oncogene, 25, 3703–3715.
Fournier TM, Lamorte L, Maroun CR, Lupher M, Band H, Langdon W and Park M . (2000). Mol. Biol. Cell, 11, 3397–3410.
Garcia-Guzman M, Larsen E and Vuori K . (2000). Oncogene, 19, 4058–4065.
Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ and Comoglio PM . (1994). EMBO J., 13, 3524–3532.
Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999). Science, 286, 309–312.
Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J and Lipkowitz S . (1999). Oncogene, 18, 3365–3375.
Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC and Lipkowitz S . (1995). Oncogene, 10, 2367–2377.
Lee PS, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DD and Stanley ER . (1999). EMBO J., 18, 3616–3628.
Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S and Yarden Y. (1999). Mol. Cell, 4, 1029–1040.
Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B and Yarden Y . (1998). Genes Dev., 12, 3663–3674.
Li BQ, Wang MH, Kung HF, Ronsin C, Breathnach R, Leonard EJ and Kamata T . (1995). Biochem. Biophys. Res. Commun., 216, 110–118.
Lupher Jr ML, Songyang Z, Shoelson SE, Cantley LC and Band H . (1997). J. Biol. Chem., 272, 33140–33144.
Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P and Comoglio PM . (1998). Oncogene, 16, 2927–2933.
Meisner H, Conway BR, Hartley D and Czech MP . (1995). Mol. Cell Biol., 15, 3571–3578.
Meisner H, Daga A, Buxton J, Fernandez B, Chawla A, Banerjee U and Czech MP . (1997). Mol. Cell Biol., 17, 2217–2225.
Meng F and Lowell CA . (1998). EMBO J., 17, 4391–4403.
Miyake S, Mullane-Robinson KP, Lill NL, Douillard P and Band H . (1999). Biol. Chem., 274, 16619–16628.
Morrison AC and Correll PH . (2002). J. Immunol., 168, 853–860.
Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon W and Park M . (2001). Mol. Cell, 8, 995–1004.
Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N and Giordano S . (2002). Nature, 416, 187–190.
Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM . (1994). Cell, 77, 261–271.
Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M and Gaudino G . (1998). Oncogene, 17, 741–750.
Thien CB and Langdon WY . (2001). Nat. Rev. Mol. Cell Biol., 2, 294–307.
Thien CB, Walker F and Langdon WY . (2001). Mol. Cell., 7, 355–365.
Wang MH, Ronsin C, Gesnel M-C, Coupey L, Skeel A, Leonard EJ and Breathnach R . (1994). Science, 266, 117–119.
Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T and Yarden Y et al. (2002). EMBO J., 21, 303–313.
Waterman H, Levkowitz G, Alroy I and Yarden Y . (1999). J. Biol. Chem., 274, 22151–22154.
Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J and Birchmeier W . (1996). Nature, 384, 173–176.
Yoon CH, Lee J, Jongeward GD and Stemberg PW . (1995). Science, 269, 1102–1105.
Acknowledgements
This work was supported by grants from AIRC and COFIN-PRIN. LP was supported by EMBO fellowship ASTF 17.02.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Penengo, L., Rubin, C., Yarden, Y. et al. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene 22, 3669–3679 (2003). https://doi.org/10.1038/sj.onc.1206585
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206585
Keywords
This article is cited by
-
Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain
Cell Communication and Signaling (2014)
-
MSP–RON signalling in cancer: pathogenesis and therapeutic potential
Nature Reviews Cancer (2013)
-
Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase
Molecular Cancer (2010)
-
Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160
Journal of Experimental & Clinical Cancer Research (2008)
-
Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates
The EMBO Journal (2008)